Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference
August 31 2022 - 4:01PM
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics
company with the mission to improve patient outcomes by providing
personalized insights that inform critical decisions throughout the
patient care journey, today announced that its management team will
participate at the Lake Street 6th Annual Best Ideas Growth
Conference on Wednesday, September 14, 2022 at the Yale Club in New
York City, NY.
About OncocyteOncocyte is a precision
diagnostics company with a mission to improve patient outcomes by
providing personalized insights that inform critical decisions
throughout the patient care journey.
Through its proprietary tests and pharmaceutical
services business, the Company aims to help save lives by
accelerating the diagnosis of cancer and advancing cancer care. The
Company’s tests are designed to help provide clarity and confidence
to physicians and their patients at every stage. DetermaRx™
identifies early-stage lung cancer patients who are at high risk
for cancer recurrence and who may benefit from adjuvant
chemotherapy. DetermaIO™ is a gene expression test that assesses
the tumor microenvironment to predict response to immunotherapies.
The Company’s pipeline of tests in development also includes
DetermaTx™, which will assess mutational status of a tumor,
DetermaCNI™, a blood-based monitoring test, DetermaMx™, a long-term
recurrence monitoring test, and VitaGraft™, a blood-based solid
organ transplantation monitoring test. In addition, Oncocyte’s
pharmaceutical services provide companies that are developing new
cancer treatments a full suite of molecular testing services to
support the drug development process.
DetermaRx™, DetermaIO™, DetermaTx™, DetermaCNI™,
DetermaMx™ and VitaGraft™ are trademarks of Oncocyte
Corporation.
Investor & Media Contact
Caroline CornerICR WestwickeTel: 415.202.5678
caroline.corner@westwicke.com
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Oncocyte (NASDAQ:OCX)
Historical Stock Chart
From Sep 2023 to Sep 2024